Acute enoxaparin treatment widens the therapeutic window for tPA in a mouse model of embolic stroke. - Wikidata - awgldk - TriplyDB

Acute enoxaparin treatment widens the therapeutic window for tPA in a mouse model of embolic stroke.

Acute enoxaparin treatment widens the therapeutic window for tPA in a mouse model of embolic stroke.

http://www.wikidata.org/entity/Q33286104

about

C-terminal ADAMTS-18 fragment induces oxidative platelet fragmentation, dissolves platelet aggregates, and protects against carotid artery occlusion and cerebral stroke Statins improve the resolution of established murine venous thrombosis: reductions in thrombus burden and vein wall scarring A concerted appeal for international cooperation in preclinical stroke research Dissolution of arterial platelet thrombi in vivo with a bifunctional platelet GPIIIa49-66 ligand which specifically targets the platelet thrombus Biosensors for brain trauma and dual laser doppler flowmetry: enoxaparin simultaneously reduces stroke-induced dopamine and blood flow while enhancing serotonin and blood flow in motor neurons of brain, in vivo.

P2860

Q24310892-6C8A3849-4C8B-4382-9E54-45FD318FA814 Q27317154-12FD2D69-0AEF-40AD-8DA1-8628A9B4AC4E Q28658665-1C7E0BAB-E152-44B9-B600-4A3E6505C608 Q33389941-3DDBFF5F-5078-4699-AE7C-987B23A1D12F Q34162070-78800979-1A13-4AF1-85E1-69D295F40D5F

P2860

Acute enoxaparin treatment widens the therapeutic window for tPA in a mouse model of embolic stroke.

http://www.wikidata.org/entity/Q33286104

description

2007 nî lūn-bûn

@nan

2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Acute enoxaparin treatment wid ...... mouse model of embolic stroke.

@ast

Acute enoxaparin treatment wid ...... mouse model of embolic stroke.

@en

Acute enoxaparin treatment wid ...... mouse model of embolic stroke.

@nl

type

label

Acute enoxaparin treatment wid ...... mouse model of embolic stroke.

@ast

Acute enoxaparin treatment wid ...... mouse model of embolic stroke.

@en

Acute enoxaparin treatment wid ...... mouse model of embolic stroke.

@nl

prefLabel

Acute enoxaparin treatment wid ...... mouse model of embolic stroke.

@ast

Acute enoxaparin treatment wid ...... mouse model of embolic stroke.

@en

Acute enoxaparin treatment wid ...... mouse model of embolic stroke.

@nl

P1433

Q33286104-FD8B759D-8FF8-4A55-8EAE-39C8C5A48344

P1476

Q33286104-474C74BC-195F-4159-9BAC-06667B8E12E8

P2093

Q33286104-164DB8B6-4E3F-40A4-8657-C77D396A4AD3

Q33286104-8DDEC1BE-5B08-46FC-9AFD-DBAF4931DB97

Q33286104-F18D2454-DCDA-4055-82BC-83DC5244EBE0

P2860

Q33286104-1E174AE6-86CF-4D68-A92E-5C0C45C4009F

Q33286104-2F365DA3-BCD3-4BF0-8F57-4408C2CBFA70

Q33286104-3EB7BD48-7E9C-45BF-801E-AC2828ADA1F7

Q33286104-402B23A4-406A-43D0-81EA-DECD5531D137

Q33286104-54198DCD-762E-48FF-963E-E4D505D0B2AB

Q33286104-566CDE4F-2CB1-45DC-9193-28F26611BEF3

Q33286104-5B2BFC62-F51C-4F0C-B236-F88F0D9BE871

Q33286104-6106B48C-72EA-4720-BA5D-208D58F788B3

Q33286104-8BA90A90-FCAC-475F-BA24-0E4F787B85A9

Q33286104-91E16E39-06A6-4221-924F-9DC43B4D8F35

P304

Q33286104-220370F5-436F-471A-8035-E3AF6ACF6FE8

P31

Q33286104-1937046F-549F-4293-904C-75E54DCCBB5B

P356

Q33286104-2EAFA1EB-6727-4D90-A69F-65F4B15C4634

P433

Q33286104-2FCFAE22-04CA-4B0D-8FD7-1CDA3C5AF5CE

P478

Q33286104-0FB1BC8B-2579-496E-864E-E36A879029E9

P577

Q33286104-D00C2634-EDF5-41A2-BF05-83A3C86E9447

P698

Q33286104-59B888EF-DBDA-464C-B113-D7FFA757F445

P356

016164107X164102

P1433

Neurological Research

P1476

Acute enoxaparin treatment wid ...... mouse model of embolic stroke.

@en

P2093

David Quartermain

http://www.w3.org/2001/XMLSchema#string

Saran Jonas

http://www.w3.org/2001/XMLSchema#string

Yong-Sheng Li

http://www.w3.org/2001/XMLSchema#string

P2860

Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3.

Enoxaparin in experimental stroke: neuroprotection and therapeutic window of opportunity.

Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke.

Tissue plasminogen activator plus glutamate antagonist improves outcome after embolic stroke.

Stilbazulenyl nitrone, a novel antioxidant, is highly neuroprotective in focal ischemia.

The low molecular weight heparin enoxaparin reduces infarct size in a rat model of temporary focal ischemia.

Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain.

Efficacy of inhaled steroids in undiagnosed subjects at high risk for COPD: results of the detection, intervention, and monitoring of COPD and asthma program.

Enoxaparin, a low molecular weight heparin decreases infarct size and improves sensorimotor function in a rat model of focal cerebral ischemia.

Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study.

P304

469-475

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1179/016164107X164102

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2007-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17535591

http://www.w3.org/2001/XMLSchema#string